Abstract
Herein we described the clinical, radiological, histological and molecular characteristics of seven soft tissue aneurysmal bone cyst (STABC) diagnosed and managed at a tertiary cancer center and to elucidate its relationship with myositis ossificans (MO). All cases had established imaging and histopathological diagnosis of STABC and were subject to fluorescent in situ hybridization (FISH) for USP6 rearrangement and Archer® FusionPlex® targeted RNA sequencing analysis (RNASeq) to identify the fusion partner. A thorough literature review of STABC and MO was conducted. The patients presented with painful masses unpreceded by trauma, occurring most commonly in the deep soft tissue of the thigh/gluteus (4/7), and also in the supraclavicular region, the axilla, and the hand. On imaging, the lesions were frequently associated with peripheral calcification on conventional radiographs and CT (6/7), cystic components on ultrasound and MRI, as well as perilesional edema (7/7) and fluid levels (3/7) on MRI. Bone scan (1/1) showed intense radiotracer uptake. Histologically, 6/7 cases demonstrated zonal arrangements reminiscent of MO. USP6 rearrangement was found in all seven cases by FISH and/or RNASeq. RNASeq further detected COL1A1-USP6 fusion in six cases and a novel ANGPTL2-USP6 fusion in one case. Four patients underwent resection of the tumors and were disease-free at their last follow-up. Three patients who underwent incisional or needle biopsies had no evidence of disease progression on imaging studies. In conclusion, the clinical, radiological and pathological overlap between STABC and MO suggests that they are closely related entities. A novel fusion ANGPTL2-USP6 is associated with distinct clinical and pathological presentation.
Keywords: Myositis Ossificans-like Soft Tissue Aneurysmal Bone Cyst (MO-like STABC), USP6, COL1A1, ANGPTL2, CT, MRI, Radiograph
Introduction
Although primary aneurysmal bone cyst (ABC) of bone was originally thought to be reactive when the entity was recognized by Jaffe and Lichtenstein in 19421, evidence suggesting its neoplastic nature was established when Panoutsakopoulos and colleagues2 discovered a recurrent chromosome aberration, t(16;17)(q22;p13). This was subsequently proven by Oliveira and colleagues to result in a fusion gene in which the promoter region of the osteoblast cadherin 11 gene (CDH11) at 16q22 is fused to the entire ubiquitin-specific protease 6 (USP6; alias Tre2) coding sequence at 17p13, transcriptionally upregulating the latter3,4. Alternative 5’ fusion partners to USP6 gene—THRAP3 (1p34.3), FOSL2 (2p23.2), CTNNB1 (3p22.1), CNBP (3q21.3), SEC31A (4q21.22), SPARC (5q33.1), OMD (9q22.31), PAFAH1B1 (17p13.3), COL1A1 (17q21.33), EIF1 (17q21.2), STAT3 (17q21.2) and USP9X (Xp11)—have been subsequently described5–9, whereas CDH11 remains the most common fusion partner in primary ABCs of bone.
Oliveira and colleagues tested for USP6 rearrangements in morphological mimickers of primary ABCs such as secondary ABCs, myositis ossificans (MO), brown tumor, and cherubism, and found USP6 rearrangements in 2 of 12 cases with classic radiological and histological features of MO10. Recently, MO-like lesions with USP6 rearrangement were reported under both terms of MO11,12 and STABC13. The discordance in nomenclature in part reflects the overlapping radiological and pathological features of these newly defined USP6 rearranged lesions with MO and primary bone ABC. Our cases herein referred to as MO-like STABCs emphasize this diagnostic challenge with detailed case examples and the value of molecular analysis for diagnostic confirmation. The objective of this study is two-fold — (1) to describe the clinical course, radiological characteristics, and histological features of MO-like STABC; (2) and to identify the fusion partners for USP6 by targeted RNA sequencing (RNASeq).
Material and Methods
The study was conducted at a tertiary cancer center with approval by the Institutional Review Board (protocol# 18-215).
Eight patients with MO-like STABCs diagnosed between 2009 and 2018 were identified by searching the pathology laboratory information system. Hematoxylin and Eosin (H&E) stained slides from archival formalin-fixed paraffin-embedded (FFPE) blocks were reviewed and radio-pathological correlation was performed. Specimens with sufficient tumor content (>10%) that were not subjected to acid decalcification were submitted for molecular studies.
Fluorescence in Situ Hybridization (FISH) Analysis for USP6 Rearrangement
FFPE tissue samples were tested for USP6 rearrangements by a break-apart fluorescence in situ hybridization (FISH) assay using a commercial USP6 break-apart FISH probe (Zytovision 27572 Bremerhaven Germany). FFPE tissue sections (4 mm thick) generated from FFPE blocks of tumor specimens were pretreated by deparaffinization in xylene and dehydration in ethanol. Dual-color FISH assay was conducted according to the protocol for FFPE sections from Vysis/Abbott Molecular with a few modifications. FISH analysis and signal capture were conducted on a fluorescence microscope (Zeiss, Jena, Germany) coupled with ISIS FISH Imaging System (Metasystems, Altlussheim, Germany). We analyzed 100 interphase nuclei from each tumor specimen, except for case 7, in which 50 interphase nuclei were analyzed due to regional suboptimal signal quality.
RNA Extraction and Targeted Sequencing
A minimum of 10 unstained slides were subject to deparaffinization. RNA extraction was then performed using RNeasy FFPE Kit according to the manufacturer’s protocol (Qiagen, Catalog #73504). cDNA libraries were constructed according to the Archer FusionPlex™ protocol (previously described by Zheng et al.14) with manufacturer supplied reagents including Archer® Universal RNA Reagent Kit for Illumina® (Catalog #AK-0040-8), Archer MBC adapters (Catalog #SA0040-45) and custom designed Gene Specific Primer (GSP) Pool kit. A total 346 fusion unidirectional GSPs, ranging in length from 18 to 39 base pairs, have been designed to target specific exons in 62 genes known to undergo rearrangement in tumorigenesis based on current literature15. GSPs are hybridized in either 5’-to-3’ or 3’-to-5’ direction to the relevant exons of each gene in order to enrich the cDNA libraries for known and novel fusion transcripts in combination with adapter-specific primers. The enriched amplicons were sequenced on an Illumina MiSeq instrument. A high confidence fusion event was reported when supported by a minimum of 5 breakpoint-spanning unique reads and 3 breakpoint-spanning reads with unique start sites.
Results
Clinical, radiological and pathological features
Of the 8 MO-like STABCs, one case showed USP6 rearrangement by FISH but was excluded from the study due to insufficient material for RNASeq.
The remaining 7 patients included 5 females and 2 males with a median age of 32 years (14 to 51 years). All patients presented with a painful mass without antecedent trauma. Two patients (cases 3 and 5) had symptoms for more than 6 months. These lesions ranged from 2.4 cm to 6.0 cm in greatest dimension and were located in the thigh/gluteus (4), supraclavicular region (1), axilla (1), and hand (1). Two lesions were juxtacortical (cases 2 and 6). All patients underwent imaging studies. Four lesions were solid (4/7), while others were partially cystic with fluid levels (3/7) on ultrasound and/or MRI. Peripheral calcifications were typically seen on plain radiograph and CT (5/7) at initial presentation, which increased over the course. On MRI, the lesions exhibited perilesional edema (7/7) with enhancement. Bone scan (1/1) showed intense radiotracer uptake, which markedly decreased at a follow-up bone scan. Histologically, 6/7 cases (except for case 3) had zonal growth pattern seen in classic MO, composed of (myo)fibroblastic spindle cells, multinucleated giant cells and blood-filled sinusoids in the center, in most cases confined by reactive woven bone at the periphery, while the lesion in case 3 was infiltrative with clustered calcification. FISH study in 6/7 cases showed rearrangement of USP6 with either split of the 5’ and 3’ signals or a single 3’ signal. Subsequent RNASeq detected USP6 rearrangement in all 7 cases. In 6/7 cases RNASeq showed a COL1A1-USP6 fusion. Case 3 had a novel ANGPTL2-USP6 fusion. In all cases, the breakpoints were located in exon 1 of USP6, placing the entire coding sequence of USP6 under the influence of the promoter region of COL1A1 and most likely promoter region of ANGPTL2 in case 3. (see Figure 1). Six patients (except for patient 4) were followed for a median of 26.5 months. Patient 3 underwent resection after having persistent symptoms for about 3.5 years. The remaining patients had resolved symptoms following resection or biopsy. The clinical, radiological, and pathological findings of all cases are summarized in detail in Table 1.
Table 1.
Patient | Age (years) /Sex | Site (size in cm) | Imaging findings | Pathology findings | FISH for USP6 rearrangement | Fusion partner by targeted RNA sequencing | Treatment | Clinical Outcome |
---|---|---|---|---|---|---|---|---|
1 | 32/F | Thigh, subcutaneous tissue (4.0) |
Ultrasound: Oval, partially cystic mass with mild peripheral vascular flow; Plain radiograph: (−) Calcification; MRI: Mass with thickened rim compressing and infiltrating the fascia, (+) perilesional edema, (+) fluid-fluid levels |
Classic MO-like zonation with an ossified rim and central cystic spaces | Positive | COL1A1 (exon 1)-USP6 (exon 1) | Wide resection | Disease-free at 40 months |
2 | 17/M | Supraclavicular soft tissue, juxta-cortical (2.3) |
CT: Mass with (+) peripheral calcification contiguous with periosteal reaction at the sternocleidomastoid insertion; MRI: (+) Perilesional edema, (+) fluid-fluid levels |
Classic MO-like zonation with an ossified rim and central cystic spaces | Positive | COL1A1 (exon 1)-USP6 (exon 1) | Wide resection | Disease-free at 5 months |
3 | 46/F | Gluteal region, intra-muscular (7.5) |
Ultrasound: Solid mass with (+) multifocal calcifications Plain radiograph: Multiple clustered calcifications, increased on post-biopsy studies; MRI: (+) Perilesional edema, (−) fluid-fluid levels |
Ill-defined, fat-infiltrating fibroblasts with multifocal ossifications | Positive | ANGPTL2 (exon 1)-USP6 (exon 1) | Wide resection | Mass increased in size and symptoms persisted for 38 months prior to resection |
4 | 51/F | Hypothenar soft tissue (2.4) |
Plain radiograph: Calcifications (−) at baseline but formed in 2 months; MRI: Lesion with diffuse low T1 and T2 signals and contrast enhancement, (+) extensive surrounding edema and soft tissue thickening, (−) fluid-fluid level |
An evolving MO-like lesion with vague zonation, solid | Positive | COL1A1 (exon 1)-USP6 (exon 1) | En-bloc excision | Lost to follow-up |
5 | 22/F | Axilla deep soft tissue (4.7) |
Plain radiograph and CT: Mass with (+) peripherally calcified mass, increased on post-biopsy studies; MRI: Mass displacing the brachial plexus and axillary vessels without definitive infiltration, (+) perilesional edema, (+) fluid-fluid levels |
Elements of a classic MO on biopsy, including blood-filled sinusoids | Positive | COL1A1 (exon 1)-USP6 (exon 1) | Incisional biopsy | Asymptomatic at 55 months |
6 | 14/F | Thigh, juxta-cortical (2.9) |
Plain radiograph and CT: Lesion with (+) peripheral and internal amorphous calcification, with associated periosteal reaction, increased on post-biopsy studies; MRI: Enhancing lesion in the vastus intermedius muscle, (+) perilesional edema, resolved subsequently, (−) fluid-fluid levels Bone scan: Intense radiotracer uptake, resolved on follow-up studies |
Elements of classic MO on biopsy, solid | Positive | COL1A1 (exon 1)-USP6 (exon 1) | Incisional biopsy | Asymptomatic at 16 months |
7 | 42/M | Thigh, intra-muscular |
Ultrasound: Hypoechoic solid mass beneath the superficial fascia; Plain radiograph: Peripherally calcified mass, increased on post-biopsy radiographs; MRI: Diffusely enhancing mass with no neurovascular involvement, (+) perilesional edema, resolved subsequently and (−) fluid-fluid levels |
Elements of classic MO on biopsy, including small blood-filled sinusoids | Negative (limited cells analyzed) | COL1A1 (exon 1)-USP6 (exon 1) | Needle biopsy | Asymptomatic at 3 months |
Case 1
A 32-year-old woman presented with an enlarging, painful mass in her left proximal thigh for 2 months (Figure 2). Imaging studies showed a partially cystic mass without calcification. Although the clinical and imaging presentations were suggestive of a nodular fasciitis, the clinical course was not typical. A wide resection of the mass was performed. Grossly, the mass had a thick, ossified wall and a central cystic space with hemorrhge. Microscopic examination showed a lesion with zonal phenomenon. The inner cystic areas were lined by fibroblast-like spindle cells and occasional osteoclast-like giant cells and background inflammatory cells, reminiscent of ABC. In the middle zone, osteoid was being laid down by the proliferating spindle cells, which gradually merged into the outer zone of trabeculated, osteoblast-rimmed woven bone, focally containing cartilage. The patient remained disease-free 3.5 years postoperatively.
Case 2
A 17-year-old young man noted a painful, palpable mass in his left clavicle for 6 weeks. The radiological differential diagnoses included infection, intracortical osteoid osteoma, periosteal osteoblastoma, and STABC. The lesion was resected along with the periosteum. The macro-and microscopic findings were similar to those in case 1. There was no recurrence five months after the resection.
Case 3
A 46-year-old woman noticed a mass in her left gluteus/thigh that caused soreness (Figure 3). On imaging studies, the mass continued to grow over 6 months from 5.1 cm to 6.0 cm. Clinical and radiological differential diagnoses included deep fibromatosis (desmoid tumor), nodular fasciitis, and MO. Biopsy showed fibroblastic spindle cell proliferation in a collagenized stroma. The cellularity was variable but in general low. Osteoclast-like giant cells were focally scattered around osteoid. No blood-filled cysts or reactive bone trabeculae were seen. The mass was resected 3.5 years after the initial presentation given the patient’s persistent symptoms. Gross examination showed a 7.5 × 4.2 × 2.9 cm predominantly solid, ill-defined, and lobulated mass with multifocal ossification involving the deep adipose tissue and skeletal muscle. Histologic sections showed fibroblastic proliferation that was previously seen on the biopsy infiltrating into adipose tissue with multiple haphazard foci of reactive woven bone.
Case 4
A 51-year-old woman suddenly noticed a tender lump in the hypothenar region of the left hand. A needle biopsy showed a solid fibroblastic proliferation in a loose stroma alternating with dense collagen bundles (osteoid), reminiscent of an early MO. After 3 months, the mass was extricated displaying a vague zonal pattern with markedly decreased cellularity in the center and mineralized collagen matrix at the periphery. The patient was lost to follow-up.
Case 5
A 22-year-old woman presented with left shoulder pain for 6 months. Although the main consideration radiologically was a MO, the anatomic site and protracted clinical course were rather unusual.
An open biopsy showed elements reminiscent of a MO, including fibroblastic spindle cell proliferation, osteoclast-like giant cells centered around blood-filled sinusoids, and osteoblast-rimmed woven bone maturing into lamellar bone. A resection was not performed given the proximity of the lesion to the brachial plexus and axillary vessels. The patient reported significantly improved range of motion after the open biopsy, and her axillary mass had decreased in size and residual dense calcification and remained stable at 4.5-year post-operative follow-up.
Case 6
A 14-year-old girl, an avid dancer, developed sudden pain in her right thigh 3 weeks prior to presentation (Figure 4). The pain limited her mobility and was inadequately relieved by anti-inflammatory medication. Imaging studies showed a solid, calcified lesion in the vastus intermedius muscle, with associated right femoral diaphyseal periosteal reaction and intense radiotracer uptake, raising concern for a surface osteosarcoma. No intracortical lesion was identified. Radiological differential diagnoses were broad, including solid ABC, bizarre parosteal osteochondromatous proliferation, and MO. Bone tumors such as Ewing sarcoma, osteosarcoma, or osteoblastoma were also considered. An incisional biopsy showed a solid lesion with exuberant interconnecting woven bone, favoring a benign etiology. The bony matrix was embedded within a collagnied to myxoid stroma with variably cellular fibroblastic spindle cells and thick-walled vessels. Occasional osteoclast-like giant cells were also identified, however, without associated blood-filled sinusoids. The patient was asymptomatic at the last follow-up.
Case 7
A 42-year-old man developed subacute right thigh pain and swelling. Main differential diagnoses based on imaging findings included MO and solid ABC. A needle biopsy demonstrated similar findings as those in case 5. In 3 months, the mass decreased in size and the patient’s associated pain resolved.
Discussion
Historically, “myositis ossificans”, also known as myositis ossificans circumscripta and myositis ossificans traumatica, is localized and self-limiting. The condition affects individuals of any age with a male predominance but is most commonly documented in adolescents and athletically active young adults. It is commonly agreed that trauma (e.g. stab wound, blunt trauma) or repetitive mechanical stress (e.g. “rider’s bone,” “fencer’s bone”) is the initiating event in most cases, while arthroplasty, fractures, spinal cord damage and thermal injury are also risk factors16,17. It usually presents as a localized mass, but occasionally can be infiltrative. Within a few days of trauma, radiographs show a rounded discrete soft tissue swelling. It takes about six weeks before ossifications at the periphery becomes apparent on radiography. In about two months, MO reaches its maximal size and definitive outline, then continues to mature and ossify in 5 to 6 months. Although the condition is not rare, the pathogenesis of MO has not been well elucidated. Earlier authors placed MO in a middle ground between inflammatory process and a neoplasm, while some pathologists favor it to be a true neoplasm16,18,19. Undoubtedly MO is a benign process and may involute over time, therefore can be conservatively managed. But it may present to the pathologist as a pseudosarcomatous soft tissue tumor, particularly during its rapidly developing phase and when it arises in the juxta-cortical location, radiographically mimicking osteochondroma or osteosarcoma (as in case 6). If biopsied, the histology may display a highly cellular osteoblastic proliferation with osteoid or woven bone formation. However, MO has a characteristic “zonal phenomenon,” composed of a well-delimited outer rim of bony spicules, a central area of proliferating fibroblastic spindle cells with multinuclear giant cells, and a transition zone of osteoblasts with islands of immature bone. The circumscription with zonation usually separates MO from the more ominous infiltrating surface osteosarcomas however deceptively benign the cytology the latter may show.
In 1992, Amir et al.20 reported a MO that spontaneously occurred in a 15-year-old girl, which contained a central radiolucent area made up of multiple blood-filled, cyst-like spaces. This lesion was interpreted as MO with ABC changes. Following this report, Rodríguez-Peralto et al.21 first used the term “primary aneurysmal cyst of soft tissues” in describing a MO-like lesion with histological features identical to those found in ABC of bone. More STABCs were described in the literature and almost all of them had overlapping clinical and radiological features of MO10,12,13,22–31(Table 2). As with MO, STABC affects patients with a wide age distribution (6-62, mean age 30 years) without gender prediliction and presents as a painful, rapidly enlarging mass. The thigh, gluteus, upper arm, shoulder and axilla are most commonly affected regions. Although in previous reports cystic components were common on imaging studies13,25, fluid-fluid levels on MRI were only present in 3/7 (43%) of our cases, which may be explained by different temporal stages. In the current standard care for MO-like lesions, a biopsy is only performed when the clinical presentation deviates from a classic MO, making watchful waiting clinically untenable. Thus there is a selection bias in STABC and therefore, suggested clinical and radiological features to differentiate STABC from MO such as lack of perceived trauma and protracted clinical course are not entirely specific.
Table 2.
Authors and year | Number of cases | Patient demographics and tumor location | Treatment and f/u information | Molecular analyses |
---|---|---|---|---|
Amir et al. 199220 | 1 | 15/F, groin | Excised with no recurrence | NP |
Rodríguez-Peralto et al., 199421 | 1 | 20/F, shoulder | N/A | NP |
López-Barea et al., 199522 | 1 | 57/F, upper arm | Excised with no recurrence | NP |
Shannon et al., 199723 | 1 | 29/F, retro-clavicular | Excised with no recurrence | NP |
Nielsen et al., 200224 | 5 | 8/M, shoulder; 29/F, groin; 37/F, upper arm; 28/M, upper arm; 30/F, thigh | Excised with no recurrence | 8/M, shoulder –t(17;17)(p13;q12) COL1A1-USP6 fusion5 |
Wang et al., 200425 | 1 | 21/M, gluteus | Excised with no recurrence | NP |
Ajilogba et al., 200526 | 1 | 12/F, thigh | Excised with no recurrence | NP |
Ellison et al., 200727 | 1 | 10/F, thigh | Excised with no recurrence | t(5;17)(q33;p13) |
Sukov et al., 200810 | 2 | 11/M, thigh; 36/F, thigh | N/A | Both showed USP6 rearrangement |
Pietchmann et al., 201128 | 2 | 26/F, thigh; 38/M, upper arm | Excised with no recurrence | Both showed USP6 rearrangement |
Hao et al., 201229 | 1 | 10/F, shoulder | Excised with no recurrence | NP |
Baker et al., 201530 | 1 | 41/F, upper arm | Excised with no recurrence | NP |
Jacquot et al., 201531 | 1 | 46/F, thigh | Excised with no recurrence | t(17;17)(p13;q21) COL1A1-USP6 fusion |
Bekers et al., 201811 | 11 | 24/F, perineum; 19/F, leg; 28/M, arm; 44/M, thoracic wall; 25/M, thigh; 17/F, thigh; 38/F, thigh; 32/F, thigh; 8/F, knee; 56/M, thigh; 6/F, gluteus | N/A | 8/11 cases showed USP6 rearrangement; 1/11 showed no USP6 rearrangement; 2/11 N/A |
Švajdler et al, 201912 | 15 | 44/M, thigh; 22/F, thigh; 28/M, gluteus; 35/F, thigh; 53/M, scapula; 10/M, neck; 35/M, thigh; 52/F, thigh; 19/F, arm; 31/M, thigh; 46/F, thigh; 37/F, arm; 60/M, thigh; 62/M, arm; 6/M, abdominal wall | N/A | 5/15 showed COL1A1-USP6 fusion; 2/15 showed no USP6 rearrangement on sequencing; 8/15 N/A |
Song et al., 201913 | 6 | 49/F, thigh; 34/F, thigh; 15/M, thigh; 19/F, thigh; 16/F, abdominal wall; 32/M, gluteus | Excised with no recurrence | 3/6 cases showed COL1A1-USP6 fusion; 1 additional case showed USP6 rearrangement; 2/6 cases failed FISH and RNA sequencing studies |
Our series | 7 | 32/F, thigh; 17/M, supraclavicular soft tissue; 46/F, gluteus; 51/F, hand; 22/F, axilla; 14/F, thigh; 41/M, thigh | 3/7 excised with no recurrence; 3/7 clinical stable on f/u; 1/7 lost to f/u | 6/7 cases showed COL1A1-USP6 fusion; 1/7 case showed ANGPTL2-USP6 fusion |
Abbreviations: N/A = Not available; NP = Not performed; f/u = follow-up
FISH and RNASeq studies for USP6 (chromosome 17p13.2) rearrangement in STABC5,10,13,27,28,31 have proved to be objective tools for diagnosis. The lesions in our series encompassed a variety of anatomic sites (e.g. axilla, tendon insertion site), beyond the intramuscular locations of classic MO. Still, the overlapping clinical, radiological and pathological features between STABCs and MOs suggest that they are closely related entities. Indeed, Bekers et al. stated that MO is another “transient neoplasm” characterized by recurrent rearrangement of USP6, a promiscuous fusion partner identified in primary ABC of bone, nodular fasciitis32,33, cellular fibroma of tendon sheath34, giant cell rich lesions of the small bones35 and more recently in cranial fasciitis36,37 and fibro-osseous pseudotumor of digits12,38 (Table 3).
Table 3.
Entity | Pathological features | 5’ partner genes to USP6 | Comment |
---|---|---|---|
STABC (MO-like STABC) | Circumscribed or infiltrative lesion in the skeletal muscle or associated with fascia; Most cases have MO-like histologic features with zonal growth pattern, with dymamic change over time; Early reports commonly described ABC-like cystic spaces, but solid cases have also been reported |
COL1A1, ANGPTL2 | Overlapping clinical and pathological features and growing molecular evidence suggest they are closely related entities; however, the literature on the frequency of USP6 gene rearrangement in MO is contradictory (17% 10 to 89%11) |
Classic MO and Fibro-osseous pseudotumor of digits | Circumscribed lesion in the skeletal muscle; Early (<6 weeks) lesion is cellular, composed of oval to spindle fibroblastic/osteoblastic cells in a loose collagenous to myxoid stroma. More mature lesions have a classic zonal growth pattern, with reactive woven bone forms at the periphery; Erythrocyte extravasation and osteoclast-like giant cells may or may not be evident |
COL1A111,12,38 (few cases) | |
ABC of bone | Primary lytic and expansile bone lesion with multilobulated blood-filled cystic spaces separated by fibrous septa; The fibrous septa contain cellular proliferation of fibroblastic spindle cells, osteoclast-like giant cells and reactive woven bone rimmed by osteoblasts; Solid variant lacks cystic spaces |
CDH11, CNBP, CTNNB1, EIF1, STAT3, COL1A1, PAFAH1B1, THRAP3, FOSL2, SEC31A, SPARC, RUNX2, OMD and USP9X 5−9 | Giant cell rich lesion of the small bones (“Giant cell reparative granulomas of bone” in hands and feet) harbor USP6 rearrangement35
USP6 rearrangement is not present in secondary ABC in association with benign and malignant bone tumors4 |
Nodular fasciitis | Circumscribed or infiltrative lesion in the subcutaneous tissue, composed of plump fibroblastic spindle cells in a myxoid to collagenized stroma with a tissue culture-like growth pattern; erythrocyte extravasation and osteoclast-like giant cells may or may not be evident. | MYH9, RRBP1, CALU, CTNNB1, MIR22HG, SPARC, THBS2, and COL6A2 32,33 | MYH9, SPARC, SERPINH1, and COL3A1 have been identified as partner genes to USP6 in cranial fasciitis37 |
Cellular fibroma of tendon sheath | Increased cellularity compared to classic fibroma of tendon sheath, composed of loosely formed fascicles of spindled-to-stellate fibroblasts with areas of microcystic change and erythrocyte extravasation | Unrevealed34 |
Abbreviations: ABC – aneurysmal bone cyst; STABC – soft tissue aneurysmal bone cyst; MO – myositis ossificans
While primary ABC of bone demonstrates variant translocations with multiple partners, the fusion partners for STABC has remained relatively consistent with COL1A15,13,31. COL1A1 encodes for the collagen alpha 1 polypeptide chain and mutations in the gene are associated with many inherited disorders such as osteogenesis imperfecta, Ehlers-Danlos syndrome, infantile cortical hyperostosis, and idiopathic osteoporosis39. In the neoplastic setting, this gene is well known for this diagnostic fusion with the platelet-derived growth factor B-chain (PDGFB) gene in dermatofibrosarcoma protuberans and giant cell fibroblastoma driving the constitutive activation of PDGFB gene40. COL1A1 is mapped to 17q21-17q22, with opposite orientation with USP6 at 17p13. Previous cytogenetic with subsequent RNA sequencing studies25,31 in two STABCs showed COL1A1-USP6 fusion involving exon 1 of COL1A1 and a splicing variant of USP6 exon 1 or exon 2. The RNASeq results in 6 of our cases showed consistent breakpoints in exon 1 of COL1A1 and USP6 exon 1.
Case 3 was unique for the lack of zonal growth pattern and a novel ANGPTL2-USP6 fusion. ANGPTL2 (angiopoietin related protein-2) at 9q33 is a member of vascular endothelial growth factor family, known not only for its angiogenic and antiapoptotic properties but also for its pro-inflammatory properties42. In our case, the fusion involved exon 1 of ANGPTL2 and the entire coding sequence of USP6. It is likely that ANGPTL2 also contributes with its promoter. It is unknown how these fusions recapitulate similar pathological processes within bone and soft tissue.
Oliveira and colleagues43 studied the molecular pathogenesis underlying the role of USP6 in ABCs and showed that USP6 residing in the fibrous stromal component of ABC induces transcription of matrix metalloproteinase (MMP) through activation of the nuclear factor κB (NFκB), which seems to play a role in matrix degradation, angiogenesis, and inflammatory response. More recently, an essential mediator of USP6’s pathogenic mechanism has been recognized as the Jak1-STAT3 pathway44, which act in concert with NFκB. This biological effect explains the histological features of the lesion mimicking a reparative/reactive hemorrhagic process and thus the long-term assumption that ABC was non-neoplastic albeit this was a destructive lesion of the bone. While the cell line of differentiation remains elusive, most of the reported fusion partners of ABC of bone are expressed during osteoblastic differentiation and it is suggested that the neoplastic cell could be derived from osteoblasts5. A common breakpoint is in exon 1 or 2 of the 5’ partner gene , which fuses with the first coding exon of USP6; the expected functional consequence being upregulated expression of an intact USP6 protein under the influence of the highly active promoter of the partner gene5,45.
In conclusion, MO-like STABC is a benign neoplasm with USP6 rearrangement, characterized with overlapping histological features with MO and primary bone ABC. Thigh, upper arm, and shoulder are common locations. Peripheral calcification on plain radiograph and CT, perilesional edema, and fluid-fluid levels on MRI are frequently observed radiological features. En-bloc excision is curative when the lesions cause symptoms. Majority of cases show COL1A1–USP6 fusion and herein we have described an additional case with ANGPTL2 gene as a novel fusion partner with USP6.
Acknowledgements:
The authors declare that they have no conflict of interest. This work was supported by the Department of Pathology at Memorial Sloan Kettering Cancer Center Internal Research Fund, and in part by a National Institutes of Health/National Cancer Institute Cancer Center Support Grant under award P30CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was presented in part at the Association of Molecular Pathology 2018 Annual Meeting, November 1, 2018, San Antonio, Texas, USA.
Footnotes
Disclosure/Conflict of Interest
The authors do not have conflicts of interest to disclose.
References
- 1.Jaffe HL, Lichtenstein L. Solitary unicameral bone cyst: with emphysis on the roentgen picture, the pathologic appearance and the pathogenesis. Arch Surg 1942;44:1004–1025. [Google Scholar]
- 2.Panoutsakopoulos G, Pandis N, Kyriazoglou I, Gustafson P, Mertens F, Mandahl N. Recurrent t(16;17)(q22;p13) in aneurysmal bone cysts. Genes Chromosomes Cancer 1999;26:265–266. [DOI] [PubMed] [Google Scholar]
- 3.Oliveira AM, Hsi BL, Weremowicz S. USP6 (Tre2) Fusion Oncogenes in Aneurysmal Bone Cyst. Cancer Res 2004;64:1920–1923. [DOI] [PubMed] [Google Scholar]
- 4.Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, His BL et al. USP6 and CDH11 Oncogenes Identify the Neoplastic Cell in Primary Aneurysmal Bone Cysts and Are Absent in So-Called Secondary Aneurysmal Bone Cysts. Am J Pathol 2004;165:1773–1780. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR, et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150 and OMD genes. Oncogene 2005;24:3419–3426. [DOI] [PubMed] [Google Scholar]
- 6.Panagopoulos I, Mertens F, Löfvenberg R, Mandahl N. Fusion of the COL1A1 and USP6 genes in a benign bone tumor. Cancer Genet Cytogenet 2008;180:70–73. [DOI] [PubMed] [Google Scholar]
- 7.Guseva NV, Jaber O, Tanas MR, Stence AA, Sompallae R, Schade J, et al. Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst. Genes Chromosomes Cancer 2017;56:266–277. [DOI] [PubMed] [Google Scholar]
- 8.Šekoranja D, Boštjančič E, Salapura V, Mavčič B, Pižem J. Primary aneurysmal bone cyst with a novel SPARC-USP6 translocation identified by next-generation sequencing. Cancer Genet 2018;228–229:12–16. [DOI] [PubMed] [Google Scholar]
- 9.Blackburn PR, Davila JI, Jackson RA, Fadra N, Atiq MA, Pitel BA, et al. RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cyst. Genes Chromosomes Cancer 2019;58:589–594. [DOI] [PubMed] [Google Scholar]
- 10.Sukov WR, Franco MF, Erickson-Johnson M, Chou MM, Unni KK, Wenger DE, et al. Frequency of USP6 rearrangements in myositis ossificans, brown tumor, and cherubism: molecular cytogenetic evidence that a subset of “myositis ossificans-like lesions” are the early phases in the formation of soft-tissue aneurysmal bone cyst. Skeletal Radiol 2008;37:321–327. [DOI] [PubMed] [Google Scholar]
- 11.Bekers EM, Eijkelenboom A, Grünberg K, Roverts RC, de Rooy JW, van der Geest IC, et al. Myositis ossificans – Another condition with USP6 rearrangement, providing evidence of a relationship with nodular fasciitis and aneurysmal bone cyst. Ann Diagn Pathol 2018;34:56–59. [DOI] [PubMed] [Google Scholar]
- 12.Švajdler M, Michal M, Martínek P, Ptáková N, Kinkor Z, Szépe P, et al. Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases. Hum Pathol 2019;88:39–47. [DOI] [PubMed] [Google Scholar]
- 13.Song W, Suurmeijer AJH, Bollen SM, Cleton-Jansen AM, Bovée JV, Kroon HM. Soft tissue aneurysmal bone cyst: six new cases with imaging details, molecular pathology, and review of the literature. Skeletal Radiol 2019;48:1059–1067. [DOI] [PubMed] [Google Scholar]
- 14.Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch KD, et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 2014;20:1479–1484. [DOI] [PubMed] [Google Scholar]
- 15.Zhu G, Benayed R, Ho C, Mullaney K, Sukhadia P, Rios K, et al. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma. Mod Pathol 2019;32:609. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ackerman LV. Extra-osseous localized non-neoplastic bone and cartilage formation (so-called myositis ossificans): clinical and pathological confusion with malignant neoplasms. J Bone Joint Surg Am 1958;40-A:279–298. [PubMed] [Google Scholar]
- 17.Meyers C, Lisiecki J, Miller S, Levin A, Fayad L, Ding C, et al. Heterotopic Ossification: A Comprehensive Review. JBMR Plus 2019;3:e10172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Binnie JF XIII. Myositis Ossificans Traumatica. Ann Surg 1903;38:423–440. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gruca A Myositis ossificans circumscripta: A clinical and experimental study. Ann Surg 1925;82:883–919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Amir G, Mogle P, Sucher E. Case report 729. Myositis ossificans and aneurysmal bone cyst. Skeletal Radiol 1992;21:257–259. [DOI] [PubMed] [Google Scholar]
- 21.Rodríguez-Peralto JL, López-Barea F, Sánchez-Herrera S, Atienza M, et al. Primary aneurysmal cyst of soft tissues (extraosseous aneurysmal cyst). Am J Surg Pathol 1994;18:632–636. [DOI] [PubMed] [Google Scholar]
- 22.Lopez-Barea F, Burgos-Lizaldez E, Rodríguez-Peralto JL, Alvarez-Linera J, Sanchez-Herrera S. Primary aneurysmal cyst of soft tissue: Report of a case with ultrastructural and MRI studies. Virchows Arch 1996;428:125–129. [DOI] [PubMed] [Google Scholar]
- 23.Shannon P, Bedard Y, Bell R, Kandel R. Aneurysmal cyst of soft tissue: Report of a case with serial magnetic resonance imaging and biopsy. Hum Pathol 1997;28:255–257. [DOI] [PubMed] [Google Scholar]
- 24.Nielsen GP, Smith MA, Rosenberg AE. Soft Tissue Aneurysmal Bone Cyst. Am J Surg Pathol 2002;26:6. [DOI] [PubMed] [Google Scholar]
- 25.Wang XL, Gielen JL, Salgado R, Delrue F, De Schepper AMA. Soft tissue aneurysmal bone cyst. Skeletal Radiol 2004;33:477–480. [DOI] [PubMed] [Google Scholar]
- 26.Ajilogba KA, Kaur H, Duncan R, McFarlane JH, Watt AJ. Extraosseous aneurysmal bone cyst in a 12-year-old girl. Pediatr Radiol 2005;35:1240–1242. [DOI] [PubMed] [Google Scholar]
- 27.Ellison DA, Sawyer JR, Parham DM, Nicholas R Jr Soft-Tissue Aneurysmal Bone Cyst: Report of a Case with t(5;17)(q33;p13). Pediatr Dev Pathol 2007;10:46–49. [DOI] [PubMed] [Google Scholar]
- 28.Pietschmann MF, Oliveira AM, Chou MM, Ihrler S, Niederhagen M, Baur-Melnyk A, et al. Aneurysmal Bone Cysts of Soft Tissue Represent True Neoplasms: A Report of Two Cases. J Bone Jt Surg-Am Vol 2011;93:e45-1–8. [DOI] [PubMed] [Google Scholar]
- 29.Hao Y, Wang L, Yan M, Jin F, Ge S, Dai K. Soft tissue aneurysmal bone cyst in a 10-year-old girl. Oncol Lett 2012;3:545–548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Baker KS, Gould ES, Patel HB, Hwang SJ. Soft tissue aneurysmal bone cyst: a rare case in a middle aged patient. J Radiol Case Rep 2015;9. doi: 10.3941/jrcr.v9i1.2157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jacquot C, Szymanska J, Nemana LJ, Steinbach LS, Horvai AE. Soft-tissue aneurysmal bone cyst with translocation t(17;17)(p13;q21) corresponding to COL1A1 and USP6 loci. Skeletal Radiol 2015;44:1695–1699. [DOI] [PubMed] [Google Scholar]
- 32.Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, et al. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest 2011;91:1427–1433. [DOI] [PubMed] [Google Scholar]
- 33.Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, et al. USP6 activation in nodular fasciitis by promoter-swapping gene fusions. Mod Pathol 2017;30:1577–1588. [DOI] [PubMed] [Google Scholar]
- 34.Carter JM, Wang X, Dong J, Westendorf J, Chou MM, Oliveira AM. USP6 genetic rearrangements in cellular fibroma of tendon sheath. Mod Pathol 2016;29:865–869. [DOI] [PubMed] [Google Scholar]
- 35.Agaram NP, LeLoarer FV, Zhang L, Hwang S, Athanasian EA, Hameed M, et al. USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol 2014;45:1147–1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yancoskie A, Stojanov I, Fantasia J, Edelman M. USP6 Gene Rearrangement in Cranial Fasciitis: A Report of Three Cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;124:e222. [Google Scholar]
- 37.Paulson VA, Stojanov IA, Wasman JK, Restrepo T, Cano S, Plunkitt J, et al. Recurrent and novel USP6 fusions in cranial fasciitis identified by targeted RNA sequencing. Mod Pathol 2019:1–6. [DOI] [PubMed] [Google Scholar]
- 38.Flucke U, Shepard SJ, Bekers EM, Tirabosco R, van Diest PJ, Creytens D, et al. Fibro-osseous pseudotumor of digits-Expanding the spectrum of clonal transient neoplasms harboring USP6 rearrangement. Ann Diagn Pathol 2018;35:53–55. [DOI] [PubMed] [Google Scholar]
- 39.Online Mendelian Inheritance in Man, OMIM (TM). MIM #120150. 2018. Available from: http://www.ncbi.nlm.nih.gov/omim.
- 40.Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 1997;15:95–98. [DOI] [PubMed] [Google Scholar]
- 41.Althof PA, Ohmori K, Zhou M, Bailey JM, Bridge RS, Nelson M, et al. Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization. Mod Pathol 2004;17:518–525. [DOI] [PubMed] [Google Scholar]
- 42.Thorin-Trescases N, Thorin E. Angiopoietin-like-2: a multifaceted protein with physiological and pathophysiological properties. Expert Rev Mol Med 2014;16:e17. [DOI] [PubMed] [Google Scholar]
- 43.Oliveira AM, Chou MM. The TRE17/USP6 oncogene: a riddle wrapped in a mystery inside an enigma. Front Biosci Sch Ed 2012;4:321–334. [DOI] [PubMed] [Google Scholar]
- 44.Quick L, Young R, Henrich IC, Wang X, Asmann YW, Oliveira AM, et al. Jak1–STAT3 Signals Are Essential Effectors of the USP6/TRE17 Oncogene in Tumorigenesis. Cancer Res 2016;76:5337–5347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Oliveira AM, Chou MM. USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis. Hum Pathol 2014;45:1–11. [DOI] [PubMed] [Google Scholar]